Leuprolide acetate 3.75mg; depot susp for IM inj; preservative-free. Give as single IM inj into gluteal area, anterior thigh or deltoid; rotate inj sites. ≥18yrs: 3.75mg once a month for up to 3 ...
Hosted on MSN1mon
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatmentThe trial aims to enrol 210 subjects and will test two different therapy doses of 50mg and 75mg against a placebo. The trial will last 36 weeks, followed by an open-label extension for an ...
unavailable; have RPh compound an emergency supply of oral susp. from 75mg caps (see full labeling for preparation). ≥13yrs: Treatment: 75mg twice daily for 5 days. Prophylaxis: after close ...
Hosted on MSN11mon
Nuvectis reports initial data from Phase Ib ovarian cancer trialAccording to the findings, one patient on the 75mg/day dosage achieved a partial response (PR), with a complete response (CR) in her non-target lymph node disease, although this PR remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results